HNF1A and type 2 diabetes mellitus: MODY3 results from the pathogenic effect of gene mutations (high allelic heterogene -HNF1A) characterized by progressive insulin secretion defect, decreased renal threshold for glucose reabsorption, lean, on-autoimmunity mediated, onset of non-Insulin-dependent diabetes mellitus (NIDDM) at an early age.